The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 30th 2025
The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.
Cutting Copayments Improves Outcomes for Minority Patients After Heart Attack
May 19th 2014When nonwhite heart attack patients were able to obtain cardiovascular medications without a copayment, their readmission rates for a major vascular event or coronary revascularization dropped significantly.
Read More
Spironolactone Produces Mixed Results in Heart Failure Patients with a Preserved Ejection Fraction
May 14th 2014Trial finds that spironolactone significantly reduced hospitalization for heart failure in heart failure patients with a preserved ejection fraction but failed to decrease the incidence of the trial's primary composite outcome.
Read More